Panadol (brand)

The medication paracetamol (INN) ( or ), also known as acetaminophen (USAN) (), is sold around the world under a number of different brand names. Common brand names include Tylenol, Excedrin, Calpol, and Panadol.

Tylenol

Tylenol is a brand of drugs advertised for reducing pain, reducing fever, and relieving the symptoms of allergies, cold, cough headache, and influenza. The active ingredient of its original flagship product is paracetamol. The brand name "Tylenol" is owned by McNeil Consumer Healthcare, a subsidiary of Kenvue. As of 2017 the brand was used in Brazil, Canada, China, Egypt, Lebanon, Myanmar, Oman, Philippines, Portugal, Switzerland, Thailand, United States, and Vietnam.

Calpol

Calpol is a brand of children's medicine sold in the UK, Ireland, India, Cyprus, Hong Kong, Kenya, Malta, Philippines and Turkey. The main product is a paracetamol suspension, branded as ''Calpol Infant Suspension''. It is usually a coloured syrup with a sweet taste, and is used to treat fever and pain. In 2016 it was the second biggest selling branded over-the-counter medication sold in Great Britain, with sales of £66.3 million.

Calpol also comes in a form containing ibuprofen, marketed under the name Calprofen. Calpol Night, a product containing paracetamol and an antihistamine, was listed for use from 2+ months. However, this was changed and it is now only considered suitable for children over the age of 6 years.

History

Calpol was launched in 1959 by English pharmaceutical company, Calmic Ltd, based in Crewe, Cheshire; the company's name was an abbreviation of Cheshire and Lancashire Medical Industries Corporation, which moved from Lancashire to Crewe Hall in 1947. The Calpol brand name is likely a combination of 'Calmic' and 'paracetamol'. Calmic was acquired by Wellcome (today GlaxoSmithKline) in 1966, and Calpol became one of Wellcome's best-selling UK products in the 1980s. The brand was later owned by Pfizer Consumer Healthcare, which was acquired by Johnson & Johnson in 2006. Calpol is today a brand of Johnson & Johnson's McNeil Consumer Healthcare subsidiary; in 2020, Calpol was the UK's top-selling paediatric analgesic product with sales worth £60.1 million.

Panadol

Panadol is one of Haleon's trade names for paracetamol or acetaminophen. According to Haleon, Panadol is marketed in 85 countries, including Australia, Bahrain, Barbados, Belgium, Brazil, Bulgaria, Chile, Egypt, Finland, France, Greece, Honduras, Hong Kong, Indonesia, Ireland, Italy, Kenya, Korea, Lebanon, Macao, Malaysia, Netherlands, New Zealand, Nigeria, the Philippines, Peru, Puerto Rico, Pakistan, Qatar, Romania, Saudi Arabia, Singapore, South Africa, Sri Lanka, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Turkey, the United Arab Emirates, the United Kingdom, Vietnam, Malta, Uruguay, North Korea and Oman.

History

After it was first introduced only in clinics in 1953, Panadol started its commercial business in 1955 by Phillips, Scott & Turner, which was acquired by Frederick Stearns & Co, a subsidiary of Sterling Drug Inc. It was advertised as being "gentle on the stomach", since other analgesic agents at the time contained aspirin, a known stomach irritant. In 1955, Panadol was introduced to hospitals in the United Kingdom. Panadol was originally available only by prescription in the UK, but is now available over the counter. In 1983, Sterling introduced Panadol to the United States market. In 1988 Sterling Winthrop was acquired by Eastman Kodak which sold the worldwide over the counter drug business to SmithKline Beecham in 1994. Two weeks later, SmithKline Beecham sold the over-the-counter medication business in the United States, Canada and Puerto Rico to Bayer for US$1 billion. However, North American rights to Panadol were retained by SmithKline. It has been called "one of the most-frequently counterfeited medicines in the world."

Other formulations and packaging

Panadol is sold in different formulations and packaging with different names.

''Panadol Extra'', an S2 pharmacy-only medicine in Australia, combines 65 mg of caffeine with 500 mg of paracetamol per tablet. Caffeine may improve the analgesic effect of paracetamol. Studies have reached conflicting conclusions regarding the clinical significance of this incremental pain relief.

''Panadol Osteo'' and ''Panadol Extend Tablets'' are modified-release formulations of paracetamol. ''Panadol Osteo'' is marketed in Australia and New Zealand; its immediate to sustained release ratio is 33% to 66%.

''Panadol Rapid Handipak'' is ''Panadol Rapid'' packaged in a slim container of ten 500 mg caplets, designed to appeal to Australian women who are 20 to 35 years of age.

''Panadol Cold and Catarrh'' contains three active ingredients: paracetamol, phenylephrine hydrochloride as a nasal decongestant, and chlorpheniramine maleate to prevent certain allergies.

''Panadol Cold and Flu'' and ''Panadol Fever and Congestion'' both combine paracetamol with phenylephrine hydrochloride as a nasal decongestant.

Other brand names

References

{{DEFAULTSORT:Paracetamol Brand Names, List Of
Analgesics
Antipyretics
Lists of brands
Phenols